Literature DB >> 16371117

Genetic influence on thrombotic risk markers in the elderly--a Danish twin study.

E M Bladbjerg1, M P M de Maat, K Christensen, L Bathum, J Jespersen, J Hjelmborg.   

Abstract

OBJECTIVE: Several hemostatic variables are identified as cardiovascular risk markers. In young and middle-aged individuals, plasma concentrations of these variables are partly determined by genetic factors. The genetic contribution to cardiovascular disease (CVD) decreases with increasing age, and it is therefore important to determine the heritability of hemostasis also in the elderly.
METHODS: The heritability of plasma levels of factor VII, fibrinogen, tissue factor, tissue factor pathway inhibitor, von Willebrand factor, thrombin activatable fibrinolysis inhibitor (TAFI), and D-dimer was determined in 130 monozygotic and 155 dizygotic same-sex twin pairs, aged 73-94 years, who participated in the Longitudinal Study of Aging of Danish Twins. Furthermore, we determined the influence of promoter polymorphisms in corresponding genes on the plasma level variation.
RESULTS: Genetic factors accounted for 33% (D-dimer) to 71% (TAFI) of the variation in plasma levels. Polymorphisms were associated with concentrations of FVII and TAFI in sib-pair based analyses, but in linkage analyses the polymorphisms did not explain a significant part of the genetic variation for any of the variables.
CONCLUSIONS: Concentrations of hemostatic variables have a substantial genetic variation in the elderly, but in this study the promoter polymorphisms only explained a minimal part of this variation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371117     DOI: 10.1111/j.1538-7836.2005.01778.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  21 in total

1.  Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Authors:  A B Ozel; B McGee; D Siemieniak; P M Jacobi; S L Haberichter; L C Brody; J L Mills; A M Molloy; D Ginsburg; J Z Li; K C Desch
Journal:  J Thromb Haemost       Date:  2016-08-19       Impact factor: 5.824

2.  Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.

Authors:  J Dennis; V Truong; D Aïssi; A Medina-Rivera; S Blankenberg; M Germain; M Lemire; L Antounians; M Civelek; R Schnabel; P Wells; M D Wilson; P-E Morange; D-A Trégouët; F Gagnon
Journal:  J Thromb Haemost       Date:  2016-09-17       Impact factor: 5.824

3.  The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity.

Authors:  Laura L Swystun; Jesse D Lai; Colleen Notley; Ilinca Georgescu; A Simonne Paine; Jeff Mewburn; Kate Nesbitt; Kai Schledzewski; Cyrill Géraud; Julia Kzhyshkowska; Sergij Goerdt; Wilma Hopman; Robert R Montgomery; Paula D James; David Lillicrap
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

4.  Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.

Authors:  Janine E van Loon; Frank W G Leebeek; Jaap W Deckers; Diederik W J Dippel; Don Poldermans; David P Strachan; Weihong Tang; Christopher J O'Donnell; Nicholas L Smith; Moniek P M de Maat
Journal:  Circ Cardiovasc Genet       Date:  2010-12

5.  A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels.

Authors:  Maria Sabater-Lleal; Alfonso Buil; Juan Carlos Souto; Laura Alamsy; Montserrat Borrell; Mark Lathrop; John Blangero; Jordi Fontcuberta; José Manuel Soria
Journal:  Hum Genet       Date:  2008-06-18       Impact factor: 4.132

6.  Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Gail P Jarvik; Leslie A Lange; Mary Cushman; Russell P Tracy; Alexander P Reiner
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

7.  Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.

Authors:  Karl C Desch; Ayse B Ozel; David Siemieniak; Yossi Kalish; Jordan A Shavit; Courtney D Thornburg; Anjali A Sharathkumar; Caitlin P McHugh; Cathy C Laurie; Andrew Crenshaw; Daniel B Mirel; Yoonhee Kim; Cheryl D Cropp; Anne M Molloy; Peadar N Kirke; Joan E Bailey-Wilson; Alexander F Wilson; James L Mills; John M Scott; Lawrence C Brody; Jun Z Li; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

8.  Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins.

Authors:  Shaoyong Su; Harold Snieder; Andrew H Miller; James Ritchie; J Douglas Bremner; Jack Goldberg; Jun Dai; Linda Jones; Nancy V Murrah; Jinying Zhao; Viola Vaccarino
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

Review 9.  Genetic regulation of plasma von Willebrand factor levels in health and disease.

Authors:  L L Swystun; D Lillicrap
Journal:  J Thromb Haemost       Date:  2018-10-30       Impact factor: 5.824

10.  Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.

Authors:  A P Reiner; L A Lange; N L Smith; N A Zakai; M Cushman; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-06-22       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.